Depends on where you valued AVR at now. The 2nd VIV in a different Canadian cardiac centre would suggest that we are now the only game in town for VIV which in itself is a 3b market space. Lack of viable alternatives as suggested by the KOLs would mean that DuAVR would hit the market sooner than we think. SO we are valued at 200m USD which is a joke, so even if a US insto takes us to 2B AUD now, it may just be fair value .
Ann: Exceptional Results in Second Valve-in-Valve Case, page-10
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |